Drug-labels.com

SPC-Cefprozil (Sun Pharma Canada, 250 mg, 500 mg): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
250 mg, 500 mg
ATC code:

Patient Medication Information: uses, side effects, how to take - SPC-Cefprozil (Sun Pharma Canada, 250 mg, 500 mg)

ABOUT THIS MEDICATION

SPC-Cefprozil is the generic brand name for a drug called cefprozil.

What the medication is used for:

The most common uses of SPC-Cefprozil are:

  • respiratory infections
  • urinary tract infections
  • skin infections
  • acute sinusitis

Antibacterial drugs like SPC-Cefprozil treat only bacterial infections. They do not treat viral infections such as the common cold. Although you may feel better early in treatment, SPC-Cefprozil should be used exactly as directed. Misuse or overuse of SPC-Cefprozil could lead to the growth of bacteria that will not be killed by –SPC-Cefprozil (resistance). This means that –SPC-Cefprozil may not work for you in the future. Do not share your medicine.

For other possible uses, please speak to your doctor or pharmacist.

What it does:

SPC-Cefprozil is an antibiotic.

When it should not be used:

Do not use if allergic to cefprozil or any of the nonmedicinal ingredients present in SPC-Cefprozil (See “What the important non-medicinal ingredients are” section below).

What the medicinal ingredient is:

cefprozil as cefprozil monohydrate

What the important nonmedicinal ingredients are:

SPC-Cefprozil Tablets contain the following nonmedicinal ingredients: hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium starch

glycolate, talc and titanium dioxide.

What dosage forms it comes in:

Tablets, 250 mg and 500 mg

WARNINGS AND PRECAUTIONS

Before starting SPC-Cefprozil and to get the best possible treatment, be sure to tell your doctor if you:

  • Are allergic to penicillins, cephalopsporins, cefprozil or any other drugs.
  • Do not use if you are pregnant, plan to become pregnant or are breastfeeding.

  • Do not use for children below the age of 6 months.

  • Caution is required when cefprozil is used for the chronically ill or institutionalized elderly.

Drugs that may interact with SPC-Cefprozil include: aminoglycoside antibiotics and probenecid.

Before you use SPC-Cefprozil talk to your doctor or pharmacist.

PROPER USE OF THIS MEDICATION

Adults (13 years and older)

Usual dose:

Respiratory and Urinary Tract Infections: 500 mg once daily.

Skin Infections: 250 mg every 12 hours or 500 mg once daily.

Acute Sinusitis: 250 mg or 500 mg, every 12 hours.

Overdose:

Call your doctor or pharmacist right away in case of an overdose.

If you think that you or a person you are caring for have taken too much SPC-Cefprozil, contact your healthcare professional, hospital emergency department or regional poison control centre or Health Canada’s toll-free number, 1-844-POISON-X (1-844-764-7669) immediately, even if there are no signs or symptoms.

Missed Dose:

Call your doctor or pharmacist right away in case of a missed dose.

INTERACTIONS WITH THIS MEDICATION

IMPORTANT: PLEASE READ

PrSPC-Cefprozil – Product Monograph Page 26 of 26 SIDE EFFECTS AND WHAT TO DO ABOUT THEM

The most common side effects are diarrhea, nausea, vomiting

and abdominal pain.

This is not a complete list of side effects. For any unexpected effects while taking SPC-Cefprozil, contact your doctor or pharmacist.

Serious side effects and what to do about them

Symptom/effectTalk to your healthcare professional

Stop taking drug and get immediate

medical help

Only if severeIn all cases

Severe Cutaneous Adverse Reactions

(SCAR) (severe skin reactions that may also affect other organs):

  • Skin peeling,

    scaling, or

    blistering (with or without pus) which may also affect your eyes, mouth, nose or genitals, itching, severe rash, bumps under the skin, skin pain, skin color changes (redness,

    yellowing,

    purplish)

  • Swelling and

    redness of eyes or face

  • Flu-like feeling, fever, chills, body aches, swollen glands, cough
  • Shortness of

    breath, chest pain or discomfort

✓

HOW TO STORE IT

Remember to keep SPC-Cefprozil well out of reach and sight of children. SPC-Cefprozil should be stored at room temperature (15-30oC) and protected from light and excessive humidity.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction

    Reporting (canada.ca/drug-device-reporting) for information on how to report online, by mail or by fax; or

  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about SPC-Cefprozil:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this patient medication information by visiting the Health Canada website (Drug Product Database: Access the database

    • Canada.ca) or by calling 1-866-840-1340.

Last revised: JUN 18, 2025

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02293528

Revision date stated in the text: June 18, 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for SPC-Cefprozil (Sun Pharma Canada, 250 mg, 500 mg)

Rx or OTC
Prescription (Rx)?
DIN 02293528, 02293536
Schedule(s) PRESCRIPTION
Active ingredient(s) Cefprozil (cefprozil monohydrate)
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J01 Antibacterials for systemic use
      1. J01D Other beta-lactam antibacterials
        1. J01DC Second-generation cephalosporins
          1. J01DC10 Cefprozil
Company SUN PHARMA CANADA INC
Current status Marketed
Current status date June 18, 2025
Strengths and forms
DIN Strength Dosage form(s) Current status
02293528 250 MG Tablet Marketed June 18, 2025
02293536 500 MG Tablet Marketed June 18, 2025

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.